Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

726 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Magnetic resonance evaluation of brain metastases from systemic malignances with two doses of gadobutrol 1.0 m compared with gadoteridol: a multicenter, phase ii/iii study in patients with known or suspected brain metastases.
Katakami N, Inaba Y, Sugata S, Tsurusaki M, Itoh T, Machida T, Tanaka H, Nakayama T, Morikawa T, Breuer J, Aitoku Y. Katakami N, et al. Among authors: breuer j. Invest Radiol. 2011 Jul;46(7):411-8. doi: 10.1097/RLI.0b013e3182145a6c. Invest Radiol. 2011. PMID: 21467949 Clinical Trial.
A multicenter, randomized, controlled, single-blind comparison phase III study to determine the efficacy and safety of gadobutrol 1.0 M versus gadopentetate dimeglumine following single injection in patients referred for contrast-enhanced MRI of the body regions or extremities.
Kuwatsuru R, Takahashi S, Umeoka S, Sugihara R, Zeng M, Huan Y, Peng W, Ma L, Guo L, Teng G, Yao W, Tozaki M, Endo M, Kaji S, Ro T, Tae Hahn S, Chul Kang B, Nishimura H, Sugawara Y, Katakami N, Breuer J, Aitoku Y. Kuwatsuru R, et al. Among authors: breuer j. J Magn Reson Imaging. 2015 Feb;41(2):404-13. doi: 10.1002/jmri.24566. Epub 2014 Apr 1. J Magn Reson Imaging. 2015. PMID: 24692302 Clinical Trial.
Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.
Ichikawa T, Saito K, Yoshioka N, Tanimoto A, Gokan T, Takehara Y, Kamura T, Gabata T, Murakami T, Ito K, Hirohashi S, Nishie A, Saito Y, Onaya H, Kuwatsuru R, Morimoto A, Ueda K, Kurauchi M, Breuer J. Ichikawa T, et al. Among authors: breuer j. Invest Radiol. 2010 Mar;45(3):133-41. doi: 10.1097/RLI.0b013e3181caea5b. Invest Radiol. 2010. PMID: 20098330 Clinical Trial.
Efficacy and safety of MR imaging with liver-specific contrast agent: U.S. multicenter phase III study.
Bluemke DA, Sahani D, Amendola M, Balzer T, Breuer J, Brown JJ, Casalino DD, Davis PL, Francis IR, Krinsky G, Lee FT Jr, Lu D, Paulson EK, Schwartz LH, Siegelman ES, Small WC, Weber TM, Welber A, Shamsi K. Bluemke DA, et al. Among authors: breuer j. Radiology. 2005 Oct;237(1):89-98. doi: 10.1148/radiol.2371031842. Epub 2005 Aug 26. Radiology. 2005. PMID: 16126918
Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings.
Huppertz A, Balzer T, Blakeborough A, Breuer J, Giovagnoni A, Heinz-Peer G, Laniado M, Manfredi RM, Mathieu DG, Mueller D, Reimer P, Robinson PJ, Strotzer M, Taupitz M, Vogl TJ; European EOB Study Group. Huppertz A, et al. Among authors: breuer j. Radiology. 2004 Jan;230(1):266-75. doi: 10.1148/radiol.2301020269. Radiology. 2004. PMID: 14695400 Clinical Trial.
726 results